Kidney Wilms tumor
MONDO:0019004An embryonal pediatric tumor of the kidney which may also be seen rarely in adults. The peak incidence of Wilms tumor is between the second and fifth year of life. Microscopically, it is composed of a mixture of cellular elements (blastemal, stromal, and epithelial). The most common sites of metastasis include the regional lymph nodes, lungs, and liver.
Also known as: Wilms tumor, Wilms tumour, Wilms' tumor, Wilms' tumour, Wilms tumor of the kidney, Wilms tumour of the kidney, Wilms' Tumor, Wilms' tumor of the kidney
2777 clinical trials for this condition and its sub-types, 9 tagged with Kidney Wilms tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Kidney Wilms tumor
-
Childhood kidney Wilms tumor 7 trials · 8 incl. sub-types
1 sub-type
-
Nonanaplastic kidney Wilms tumor 2 trials
-
Adult kidney Wilms tumor 1 trial
-
Epithelial predominant Wilms' tumor 0 trials
-
Metachronous kidney Wilms' tumor 0 trials
-
New hope for kids with rare cancers: drug targets tumor growth
Disease control OngoingThis phase 2 trial tests the drug cabozantinib in children and young adults with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to treatment. Cabozantinib works by blocking enzymes that help tumors grow and form blood vessels. The study a…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for kids with rare cancers: targeted drug larotrectinib tested in small trial
Disease control OngoingThis phase 2 trial is testing the drug larotrectinib in children and young adults (ages 1 to 21) with advanced solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have a specific genetic change called an NTRK fusion. The cancers have either come back after treatment…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC